⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2051796 | 1.00 | — | — | |
| SCHEMBL18721662 | 0.86 | — | — | |
| SCHEMBL15423558 | 0.82 | GRM2 (0.31) | — | |
| SCHEMBL18882180 | 0.82 | — | — | |
| SCHEMBL13336901 | 0.81 | GRM2 (0.32) | — | |
| SCHEMBL15893770 | 0.81 | GRM2 (0.32) | — | |
| SCHEMBL1952301 | 0.81 | GRM2 (0.32) | — | |
| SCHEMBL13336913 | 0.81 | GRM2 (0.32) | — | |
| SCHEMBL789445 | 0.81 | GRM2 (0.32) | — | |
| SCHEMBL5692521 | 0.81 | GRM2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2265606-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009129109-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-10-22 | — | — | WO | disclosed |